Where does Loyola University of Chicago rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Loyola University of Chicago ranks #11,333 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Loyola University of Chicago hold?

Loyola University of Chicago holds 27 US utility patents granted between 2015 and 2024, spanning 22 technology areas.

What is Loyola University of Chicago's Innovation Score?

Loyola University of Chicago has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Loyola University of Chicago focus on?

Loyola University of Chicago's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 13 patents, ranking #1,479 of 6,058 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

Is Loyola University of Chicago's patent grant rate increasing or decreasing?

Loyola University of Chicago's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Loyola University of Chicago's patents?

Loyola University of Chicago's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Loyola University of Chicago patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Loyola University of Chicago

USPTO PatentsView assignee record - 27 granted patents across 22 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Loyola ranks #11,333 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 22 technology areas.

#11,333
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.0/100): 13.5
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11333 · US Corporation #11,333 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,333/49,997
PHOTO-FINISH Leopold Kostal & KG
CPC-FOCUS A61P · 22 areas
INNOV-PAR 40.0/100
CLAIMS-RICH 13.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Leopold Kostal GmbH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Loyola’s 40.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (29%) Velocity 3.8 pts (10%) Breadth 16.6 pts (42%) Claim depth 8.1 pts (20%)

Qualcomm Incorporated · highest

85
Doheny EYE Institute · near

40
Intellectual… · near

40
Loyola University… · this assignee

40
Medallia · near

40
Tendyne Holdings · near

40
3D Lighting… · lowest

7

What this shows Loyola's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Loyola?

Each dot is one of Loyola’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Loyola’s own 13.5 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Loyola vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Loyola's grants concentrate

Loyola University of Chicago is a focused PatentsView assignee: 22 CPC subclasses with 48.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2015. By volume, Loyola sits between Leopold Kostal GmbH & Co. KG and Mavig GmbH.

Loyola's three-year grant acceleration

Loyola University of Chicago shows 8 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Leopold Kostal &…

27
Limflow

27
Liposcience

27
Lovepop

27
M E P Macchine El…

27
Magna Closures S…

27
Manitowoc Foodser…

27
Mavig

27
Loyola University… ◀

27

What this shows Loyola holds 27 patents at rank #11,333, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Loyola

By rank, the assignees closest to #11,333 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Loyola's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Loyola, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Loyola ranks #1,479 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Intellectual Property Innovation Corporation 40 Medallia, Inc. 40 Doheny EYE Institute 40 Tendyne Holdings, Inc. 40

Loyola's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Loyola University of Chicago patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.7%
2016	1	3.7%
2018	3	11.1%
2019	4	14.8%
2020	6	22.2%
2021	4	14.8%
2022	1	3.7%
2023	4	14.8%
2024	3	11.1%

Which technologies does Loyola University of Chicago patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

C07D - Heterocyclic Compounds 5

A61B - DIAGNOSIS; SURGERY; Identification 4

C07K - Peptides 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

G02B - Optical Elements, Systems OR Apparatus 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Loyola University of Chicago's patent record in context - here's where to go next.

Loyola University of Chicago's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 48.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #11,333 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Loyola University of Chicago against Leopold Kostal GmbH & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.